title: Cytotoxic T cell adjuvant effects of three Salmonella enterica flagellins.
abstract: Bacterial flagellins are important virulence-associated factors and strong inducers of inflammatory responses in mammalian hosts. Flagellins have also been investigated as potential vaccine adjuvants, either for induction of humoral or cellular immune responses, to different target antigens. In this study we investigated the adjuvant properties of three Salmonella enterica flagellins types (FliCd, FliCi and FljB) to an ovalbumin-derived CD8(+) T cell-restricted epitope (OVA257-264). Although mice immunized with the three tested flagellins elicited antigen-specific activated CD8(+) T cells, only animals immunized with FliCi and FliCd flagellins admixed with ovalbumin mounted specific in vivo cytotoxic responses to peptide-pulsed target cells. The present results indicate that Salmonella flagellins are endowed with type-specific adjuvant effects toward murine CD8(+) T cells, a feature that may impact their use as adjuvants for prophylatic or therapeutic vaccines.
authors.affiliation: Departmento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo , São Paulo, SP , Brasil.
authors.forename: Catarina J M
authors.initials: CJ
authors.lastname: Braga
authors.forename: Liliana M
authors.initials: LM
authors.lastname: Massis
authors.forename: Bruna C G
authors.initials: BC
authors.lastname: Alencar
authors.forename: Maurício M
authors.initials: MM
authors.lastname: Rodrigues
authors.forename: M E
authors.initials: ME
authors.lastname: Sbrogio-Almeida
authors.forename: Luís C S
authors.initials: LC
authors.lastname: Ferreira
keywords: Salmonella; adjuvants; cytotoxic T cells; flagellin; vaccines
references.citation: Infect Immun. 2006 Jan;74(1):694-702
references.pmid: 16369026
references.citation: J Immunol. 2003 Jul 1;171(1):27-31
references.pmid: 12816979
references.citation: J Immunol Methods. 1995 Apr 12;181(1):45-54
references.pmid: 7537312
references.citation: Nat Immunol. 2006 Mar;7(3):318-25
references.pmid: 16444259
references.citation: Infect Immun. 2004 May;72(5):2810-6
references.pmid: 15102791
references.citation: J Biol Chem. 2006 Nov 17;281(46):35217-23
references.pmid: 16984919
references.citation: Vaccine. 1995 Feb;13(3):235-44
references.pmid: 7543230
references.citation: Infect Immun. 2005 Oct;73(10):6763-70
references.pmid: 16177354
references.citation: Science. 1989 Apr 7;244(4900):70-2
references.pmid: 2468182
references.citation: Microbiol Rev. 1988 Dec;52(4):533-5
references.pmid: 3070322
references.citation: Methods. 2003 Oct;31(2):143-9
references.pmid: 12957572
references.citation: J Immunol. 2002 Oct 1;169(7):3914-9
references.pmid: 12244190
references.citation: EMBO J. 1989 Oct;8(10):3149-52
references.pmid: 2583095
references.citation: J Bacteriol. 1996 May;178(10):2911-5
references.pmid: 8631681
references.citation: PLoS One. 2007 Apr 25;2(4):e393
references.pmid: 17460760
references.citation: Science. 2004 May 14;304(5673):1014-8
references.pmid: 15143282
references.citation: Res Microbiol. 1995 Mar-Apr;146(3):203-16
references.pmid: 7569315
references.citation: Nat Immunol. 2003 Dec;4(12):1247-53
references.pmid: 14625549
references.citation: Vaccine. 2007 Jan 8;25(4):763-75
references.pmid: 16968658
references.citation: Trends Microbiol. 2004 Nov;12(11):509-17
references.pmid: 15488392
references.citation: FEMS Immunol Med Microbiol. 2001 Apr;30(3):203-8
references.pmid: 11335139
references.citation: J Biol Chem. 2004 Feb 13;279(7):5667-75
references.pmid: 14634022